Synopsis
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Solubilizers
Emulsifying Agents
Co-Processed Excipients
Surfactant & Foaming Agents
Thickeners and Stabilizers
Parenteral
Film Formers & Plasticizers
Granulation
Direct Compression
Coating Systems & Additives
Lubricants & Glidants
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Diflorasone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diflorasone, including repackagers and relabelers. The FDA regulates Diflorasone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diflorasone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diflorasone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diflorasone supplier is an individual or a company that provides Diflorasone active pharmaceutical ingredient (API) or Diflorasone finished formulations upon request. The Diflorasone suppliers may include Diflorasone API manufacturers, exporters, distributors and traders.
click here to find a list of Diflorasone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diflorasone DMF (Drug Master File) is a document detailing the whole manufacturing process of Diflorasone active pharmaceutical ingredient (API) in detail. Different forms of Diflorasone DMFs exist exist since differing nations have different regulations, such as Diflorasone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diflorasone DMF submitted to regulatory agencies in the US is known as a USDMF. Diflorasone USDMF includes data on Diflorasone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diflorasone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diflorasone suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Diflorasone Drug Master File in Japan (Diflorasone JDMF) empowers Diflorasone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Diflorasone JDMF during the approval evaluation for pharmaceutical products. At the time of Diflorasone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Diflorasone suppliers with JDMF on PharmaCompass.
A Diflorasone CEP of the European Pharmacopoeia monograph is often referred to as a Diflorasone Certificate of Suitability (COS). The purpose of a Diflorasone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diflorasone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diflorasone to their clients by showing that a Diflorasone CEP has been issued for it. The manufacturer submits a Diflorasone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diflorasone CEP holder for the record. Additionally, the data presented in the Diflorasone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diflorasone DMF.
A Diflorasone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diflorasone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diflorasone suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diflorasone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diflorasone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diflorasone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diflorasone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diflorasone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diflorasone suppliers with NDC on PharmaCompass.
Diflorasone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diflorasone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diflorasone GMP manufacturer or Diflorasone GMP API supplier for your needs.
A Diflorasone CoA (Certificate of Analysis) is a formal document that attests to Diflorasone's compliance with Diflorasone specifications and serves as a tool for batch-level quality control.
Diflorasone CoA mostly includes findings from lab analyses of a specific batch. For each Diflorasone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diflorasone may be tested according to a variety of international standards, such as European Pharmacopoeia (Diflorasone EP), Diflorasone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diflorasone USP).
LOOKING FOR A SUPPLIER?
